Hello beautiful girls.
I'm Sue and I'm from Australia. I've been visiting the forum on and off since about November last year but I've finally decided to post! I love visiting this site and listening to all your stories and I realize I'm not alone. I am encouraged by all your testimonies and I love reading all your posts.
As you can see from my profile, I was dx with OC stage 3C in March 06. Since Oct 08 I have been enrolled in a Clinical Trial comparing PARP inhibitors and Doxil.
I have the BRCA1 mutation.
Well, I was assigned to the Doxil arm (IV chemo every month). I was extremely disappointed and depressed as I wanted the PARP inhibitors because I was sick of needles and wanted the tablets instead!!
Has anyone else been on the trial, or on the trial right now (whether receiving PARP tablets or Doxil)??? Furthermore, has anyone actually switched over from the Doxil to the PARP drugs... I think it's gonna be a battle switching over to the tablets since there's this horrible requirement for tumors to have increased by 20% in order to classify as progressive disease to switch over to the other drugs. As for me, I've had 4 doses/cycles of the Doxil since October and it appears that my CA125 is rising again and that the disease is progressing. My CA125 has gone from 550 to over 1,000 after remaining at 400-500 for a couple of months. A CT scan last week showed a small increase in the size of a tumor in my lower abdomen. (I have a number of nodes/tumors in my lower abdominal cavity).
My heart is heavy for us women who are on clinical trials, fighting for life saving drugs that may help but we are prevented from trying them because of big pharma requirements and bureaucracy. I especially feel sorry for women who are on placebo drugs and they don't even know if they're getting the drugs they need.
Anywho, sorry to carry on like this, but I was just wondering if there are any others on this clinical trial I'm on... or anybody with any problems trying to get onto clinical trials, etc.
Love and God bless you all,
Sue





Add to the discussion